ID
45433
Descrição
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Uterine Cervical Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000628 In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample.
Link
Palavras-chave
Versões (1)
- 29/11/22 29/11/22 - Chiara Middel
Titular dos direitos
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Transferido a
29 de noviembre de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000628 Characterization of a Metastatic Cervical Cancer Using NGS
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Similar models
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
C0242481 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
C1511726 (UMLS CUI [1,4])